Las maniobras de resucitación son técnicas vitales que pueden marcar la diferencia entre la vida y la muerte en situaciones de emergencia. Cuando una persona experimenta un paro cardíaco o deja de respirar, actuar rápidamente y realizar las maniobras de resucitació …
Maniobras de resucitación: Cómo salvar vidas en momentos críticos Read More »
Los rayos, esos destellos de luz y sonido que iluminan el cielo durante una tormenta, han cautivado a la humanidad durante siglos. El proceso que genera un rayo comienza con la formación de nubes de tormenta. Estas nubes están compuestas por pequeñas partículas d …
Los rayos: Un fenómeno eléctrico impresionante que desafía a la naturaleza Read More »
La calvicie es un problema común que afecta a millones de personas en todo el mundo, y durante años ha sido motivo de frustración y preocupación para aquellos que la padecen. Sin embargo, en los últimos tiempos, los avances en la modificación genética …
Modificación genética: ¿La solución para el problema de la calvicie? Read More »
Nicox SA provided financial and business highlights for the second quarter 2023 for Nicox SA and its subsidiaries.
Nicox Provides Second Quarter 2023 Financial and Business Highlights Read More »
Santhera Pharmaceuticals announces the closing of the exclusive license agreement for vamorolone in North America with Catalyst Pharmaceuticals, Inc., announced on June 20, 2023.
argenx SE, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced the pricing of a global offering of ordinary shares, which may be represented by American Depository Shares.
argenx raises $1.1 billion in gross proceeds in a global offering Read More »
Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced that it has submitted a Clinical Trial Application to initiate a Phase 1/2 clinical trial of OTOF-GT in Europe.
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced first patient treated with imlifidase in an investigator-initiated phase 2 study in anti-neutrophil cytoplasmic antibody -associated vasculitis.
Biophytis SA announced that it has entered into definitive agreements for the purchase and sale of 1,333,334 units, each consisting of one American Depositary Share or one prefunded warrant giving right to one ADS and one warrant to purchase one ADS, at a purchase price of $2.85 per unit comprising an ADS and $2.84 per
Biophytis Announces $3.8 Million Registered Direct Offering Read More »
RELIEF THERAPEUTICS Holding SA announced an extension of its exclusive, long-term agreement with Pentec Health, Inc., broadening the distribution of PKU GOLIKE® in the U.S. Pentec Health is a leading provider of healthcare services for complex care challenges, including clinical nutrition and specialty care, and the exclusive distributor of PKU GOLIKE® in the U.S.
